Online inquiry

IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16075MR)

This product GTTS-WK16075MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the Androgen-binding protein protein. This product can be used in Sertoli cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001040.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 6462
UniProt ID P04278
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16075MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK23987MR IVTScrip™ mRNA-Human ATP1B3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ATP1B3
GTTS-WK10529MR IVTScrip™ mRNA-Human ABCA13, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABCA13
GTTS-WK8432MR IVTScrip™ mRNA-Human ABCA3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ABCA3
GTTS-WK23450MR IVTScrip™ mRNA-Human AQP5, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AQP5
GTTS-WK26987MR IVTScrip™ mRNA-Human ATP1B3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATP1B3
GTTS-WK21636MR IVTScrip™ mRNA-Human APOL6, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA APOL6
GTTS-WK11737MR IVTScrip™ mRNA-Human ABCB1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABCB1
GTTS-WK25518MR IVTScrip™ mRNA-Human APOB, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APOB
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW